Dasatinib may overcome the negative prognostic impact of KIR2DS1 in newly diagnosed patients with chronic myeloid leukemia

Lignende værker

• Interaction between KIR3DS1 and HLA-Bw4 predicts for progression-free survival after autologous stem cell transplantation in patients with multiple myeloma
  af: Gabriel, Ian H., et al.
  Udgivet: (2010)
• Efficacy of combining dasatinib and FLAG-IDA for patients with chronic myeloid leukemia in blastic transformation
  af: Milojkovic, Dragana, et al.
  Udgivet: (2012)
• Responses to second-line tyrosine kinase inhibitors are durable: an intention-to-treat analysis in chronic myeloid leukemia patients
  af: Milojkovic, Dragana, et al.
  Udgivet: (2012)
• Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response
  af: Kuwabara, Aya, et al.
  Udgivet: (2010)
• Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling
  af: de Lavallade, Hugues, et al.
  Udgivet: (2013)